1 / 67

Primary Care Breast Cancer Part I: Screening

Primary Care Breast Cancer Part I: Screening. Hilary Suzawa Med/Peds December 2006. Breast Cancer Incidence. One in Eight (12%) : Lifetime risk of developing invasive breast CA Breast CA is the second most commonly dx CA among women (1 st —skin CA) ~180,000 new cases annually

dard
Download Presentation

Primary Care Breast Cancer Part I: Screening

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Primary CareBreast CancerPart I: Screening Hilary Suzawa Med/Peds December 2006

  2. Breast Cancer Incidence • One in Eight (12%): Lifetime risk of developing invasive breast CA • Breast CA is the second most commonly dx CA among women (1st—skin CA) • ~180,000 new cases annually • Estimated 212,920 dx in 2006 per Up To Date • Invasive breast CA accounts for 32% of new CA cases in American women • Pre-invasive breast CA (DCIS) now accounts for ~25-30% of all newly dx breast CA detected by mammogram

  3. Breast Cancer Mortality • Second leading cause of cancer death in women (1st—lung CA) • ~48,000 deaths per year • Estimated 40,970 deaths in 2006 per Up To Date • Invasive breast CA accounts for 15% of CA deaths in American women • Main cause of death in women age 45-55 years • Annual mortality rates from breast CA have decreased over the last decade

  4. Risk Factors • Most women with breast CA have no identifiable risk factors • Female • 1% of breast CA occur in men • Incidence of breast CA increases with age

  5. Risk Factors • Race • Overall White > Black • Women <50 years: Black > White • Black women more likely to die of breast CA than white women • High social economic status

  6. Risk Factors • Personal history of breast CA • Increases the risk of developing a new breast CA by 0.5-1% per year • Early menarche and late menopause—increased exposure to hormones • Give birth to their first child after age 30 or who never become pregnant

  7. Risk Factors • OCP (?) • OCP <10 years has same risk as women who have never been on OCP • FMH: First degree relative, esp if dx pre-menopause • 3-4 x increase risk • Exposure to ionizing radiation • Eg. Survivors of Hodgkin’s Disease

  8. ????? • Chemical exposure • Alcohol consumption • Weight gain • High-fat diet • Induced abortion • Physical activity

  9. Risk Reduction • Low fat, high fiber diet • Reduced alcohol consumption • Tamoxifen, Raloxifene

  10. Genetics • ~8% of all cases of breast CA are hereditary • ~50% of these CA are related to BRCA-1 and BRCA-2 • Pre-menopausal women • Bilateral breast cancer

  11. Genetic Screening • Insurance • Job discrimination • Prophylactic mastectomy and/or oophorectomy • False-negative tests

  12. Clinical Presentations • Asymptomatic (screening only) • Breast Mass • Most common complaint • ~90% of all breast masses are benign • Fibroadenoma, Cyst • Breast Pain • Mastalgia is rarely assoc with breast CA • More common with fibrocystic change, HRT

  13. Clinical Presentations • Skin changes • Erythema, edema, retraction of the skin or nipple • Nipple discharge • Discharge associated with Breast CA • Discharge is spontaneous • Assoc with a mass • Localized to a single duct in one breast

  14. Clinical Breast ExamRecommendations • Part of Well Woman Exam • ACS recommendations • Pt age 20-39 years should have one every 3 years • Pt age 40 years and older annually

  15. Clinical Breast Exam Key Points • Sitting and Supine positions • Differences in size (asymmetry) • Different arm positions • Retraction of skin or nipple • Prominent venous patterns • Signs of inflammation or skin changes (peau d’orange) • Nipple discharge • Axillary and supraclavicular LAD • Teach self-breast exam

  16. Suspicious Findings • Mass • Solitary • Discrete • Hard • Fixed to skin or muscle (non-mobile) • Unilateral • Non-tender • Area of skin thickening • Breast CA is rarely bilateral when first dx/detected

  17. Self Breast ExamsRecommendations • ACS (American Cancer Society) recommends start at age 20 years • Teach adolescents • Monthly • Same time each month, eg. Week after menses

  18. Self Breast Exam Reminders

  19. MammogramRecommendations • American Cancer Society (ACS) and National Cancer Institute (NCI) • For asymptomatic women • Start age age 40 years • Annually • Screening women 50-75 years significantly decreases the death rate from breast CA • Screening women >75 years controversial but at any age screening detects breast CA at an earlier stage (risk-benefit analysis)

  20. Mammogram Bottom Line: Uncomfortable but Necessary and Important

  21. Mammogram False + • Women age 40-69 years have a 30% chance of false-positive screening mammogram OR breast exam over a 10-year period • False positive screening tests are higher for younger women because fewer of their breast masses are malignant (prevalence)

  22. Mammogram False - • 10-15% of all breast CA are NOT detected by mammogram • A PALPABLE breast mass that is NOT seen on a mammogram should have a diagnostic work-up • Breast ultrasound • Needle biopsy • Close follow-up

  23. Screening Recommendations Review • American Cancer Society • Age 20-39 years • Clinical breast exam every 3 years • Monthly self breast exam • Age 40 years and older • Annual mammogram • Annual clinical breast exam • Monthly self breast exam

  24. Screening Recommendations • U.S. Preventive Services Task Force (USPSTF) • Routine screening in women for breast CA every 1-2 years • Mammography alone OR mammography and annual clinical breast exam for women age 50-69 years

  25. Early Screening • Women with FMH of BRCA mutation should begin annual mammography between age 30-35 years • H/o chest radiation (XRT) • Mammograms may start as early as when patient age 20’s. • eg. h/o Hodgkin’s Disease: Children’s Oncology Group (COG) recommends start mammogram 8-10 years after chest XRT or at age 25 years (whichever later)

  26. Other Imaging • Ultrasound • To differentiate b/t solid and cystic breast mass • Helpful in younger pt with dense breast tissue • Digital Mammogram • Images may be enhanced by modifying brightness or contrast • Initial studies show that digital mammograms are as accurate as standard radiographs • Not FDA approved

  27. Evaluation of Common Problems • Cysts • Solid Masses • Nipple Discharge • Breast Pain • Pregnancy

  28. Cysts • Ultrasound • Simple cyst • Round or oval • Sharp margins • Lacks internal echoes • Posterior acoustic enhancement • Simple vs. Complex Cyst • Aspiration of simple cyst • Evaluate any masses that remain after cyst aspirated

  29. Solid Masses • Clinically suspicious mass should be followed even if normal mammogram • Ultrasound • FNA biopsy • Lumpectomy with 1-cm margin • Thickened area monitoring

  30. Nipple Discharge • Suspicious for CA: spontaneous, assoc mass, single duct, bloody • Galactorrhea— • evaluate for prolactinoma • Cytology of discharge rarely helpful • Check mammogram • Ductogram

  31. Breast Pain • Most commonly with fibrocystic change and uncommon with breast CA • Breast Exam +/- mammogram • Tx for fibrocystic breast dz • Pain meds • Firm support bra • Eliminate chocolate, caffeine • Vitamin E supplements

  32. Pregnancy • Any mass in a pregnant or lactating woman should be thoroughly evaluated. • ~2% of breast CA are dx in pregnant women • Ultrasound • FNA biopsy and cytology

  33. Susan G. Komen Foundation • Website at www.komen.org • Houston Affiliate • 713-783-9188 • Race for the Cure • Houston, TX • Planned for Saturday 10/6/2007 • Any Med/Peds runners?

  34. Gifts that Matter • Consider purchasing holiday gifts that benefit Breast CA organizations • Susan G. Komen • Ford “Warriors in Pink” • Pink Ribbon Store at www.TheBreastCancerSite.com • Beauty Suppliers: Sephora, Origins

  35. Bibliography • Apantaku L, “Breast Cancer Diagnosis and Screening.” American Family Physician 2000; 62 (3). • Hurria A, Joyce R, Come S, “Follow-up for breast cancer survivors: Patterns of relapse and long-term complications of therapy,” 3/10/06, Up To Date • Hurria A, Joyce R, Come S, “Follow-up for breast cancer survivors: Recommendations for surveillance after therapy,” 5/11/06, Up To Date • Esserman L and Stomper P,” Diagnostic evaluation and initial staging work-up of women with suspected breast cancer,” 3/29/06, Up To Date • Children’s Oncology Group Long-Term Follow-Up Guidelines at www.survivorshipguidelines.org

  36. Primary CareBreast CancerPart II: Diagnosis, Treatment, Survivor Follow-up Hilary Suzawa Med/Peds February 2007

  37. Overview • Palpable Mass • Imaging • Mammogram • Ultrasound • MRI • Breast Biopsy • Prognosis • Treatment Complications • Breast CA Survivor Follow-up • Recurrence vs. Second Primary

  38. Breast Mass • If the lesion is palpable and the estimated likelihood of malignancy is >50%, then effort should be made to have surgeon evaluate prior to any biopsy procedure • Biopsy may lead to hematoma and inflammation (confounding)

  39. Mammogram • Breast Exam alone NOT sufficient for breast CA diagnosis • Breast Cancer Detection Demonstration Project (BCDDP) • <10% of breast CA were detected solely by physical exam • >90% were identified by mammogram

  40. Mammogram Bottom Line: Uncomfortable but Necessary and Important

  41. MammogramScreening vs. Diagnostic • For women with sx or signs of breast CA, diagnostic mammogram is associated with higher sensitivity but lower specificity than screening mammogram • Note: • Sensitivity (Rule Out—“Snout”) • Specificity (Rule In–“Spin”)

  42. MammogramViews and ACR Bi-RADS • Mammogram views • Spot compression • Magnification views • Varied angled views • ACR BI-RADS scale: American College of Radiology Breast Imaging Reporting and Data System

  43. MammogramAbnormal Findings • 2 general categories of mammogram findings suggestive of breast CA • Soft tissue masses • Clustered micro-calcifications • Most specific mammographic feature of malignancy is spiculated soft tissue mass • Nearly 90% of these lesions represent invasive CA

  44. MammogramMicro-calcifications • Micro-calcifications are seen in ~60% of CA detected by mammogram • Micro-calcifications are thought to represent intra-ductal calcification in areas of necrotic tumor • Mammogram appearance alone can NOT differentiate between purely intra-ductal and invasive ductal breast CA • ie, there is NO mammogram feature of basement membrane invasion

  45. MammogramStaging • Multi-focal—several areas within one breast quadrant • Signifies disease along an entire duct • Multi-centric—multiple areas within different breast quadrants • Signifies involvement of multiple ducts • Intra-mammary LN mets • Worse prognosis

  46. Breast Ultrasound • Adjunct to mammogram • To differentiate between solid and cystic masses • Negative predictive value in a patient with palpable breast mass and a non-suspicious mammogram is high (>99%) • Simple cysts need no further intervention because risk of CA is very low

  47. Breast MRI • Nearly all breast invasive CA enhance on gadolinium contrast-enhanced MRI • Possible uses • Clinical staging • Screening of contra-lateral breast • Evolving role

  48. Breast Biopsy • If pt has suspicious mammogram OR palpable mass, then biopsy • Percutaneous FNA • Percutaneous core needle biopsy • Vacuum-assisted biopsy • Wire localization and excision

  49. Breast Biopsy • Fine-needle aspiration (FNA) • 20-gauge needle for sample from solid mass for cytology • Ultrasound or stereo-tactic guidance to assist in collecting FNA from a non-palpable mass • Core Biopsy • 14-gauge needle to remove cores of tissue from a mass • Ultrasound or stereo-tactic guidance • Small skin incision and local anesthesia

  50. Breast Biopsy • Excisional Biopsy • May be the initial procedure of choice if high probability of malignancy • Wire localization of the mass if not palpable • Local anesthesia • May be done as outpatient

More Related